Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 2,615 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Sleep-Wake Disorders Clear all

Conditions: Sleep Apnea
Interventions: RAM sensor; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: Up to 70 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obstructive Sleep Apnea (OSA)
Interventions: additional educational material, Standard of care; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease
Interventions: Carvedilol; Drug
Lead sponsor: Michele Tagliati, MD; Other
Eligibility: 50 Years to 85 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obstructive Sleep Apnea
Interventions: RXiBreeze PAP System, Model RXiBreeze 20A; Device
Lead sponsor: Resvent Holding USA LTD; Industry
Eligibility: 22 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 9
States / cities: Burlingame, California • Chula Vista, California • Mountain View, California + 6 more

Conditions: Respiratory Depression, Obstructive Sleep Apnea
Interventions: Fentanyl; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 2 Years to 8 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Insomnia, Spinal Cord Injury, Tetraplegia, Sleep Disorders
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Sleep-Disordered Breathing, Sleep Architecture
Interventions: Belun Ring, PSG; Device · Diagnostic Test
Lead sponsor: Belun Technology Company Limited; Other
Eligibility: 18 Years to 80 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sleep Deprivation, Sleep Restriction
Interventions: Controlled sleep; Behavioral
Lead sponsor: Civil Aerospace Medical Institute; Federal
Eligibility: 20 Years to 45 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Boston, Massachusetts • Oklahoma City, Oklahoma

Conditions: Obstructive Sleep Apnea
Interventions: Dronabinol; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Up to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sleep Apnea, Central, Sleep Disordered Breathing, Heart Failure
Interventions: Treatment Group (transvenous stimulation of the phrenic nerve), Control Group (Optimal Medical Therapy); Device
Lead sponsor: Respicardia, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 23
States / cities: Los Angeles, California • Jacksonville, Florida • Downers Grove, Illinois + 19 more

Conditions: Sleep Apnea, Gastroesophageal Reflux Disease
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Insomnia Chronic, Insomnia, Insomnia, Primary, Depression, Depressive Symptoms
Interventions: Cognitive Behavioral Therapy for Insomnia (CBT-I); Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sleep Apnea
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2024
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Delayed Sleep-Wake Phase Disorder
Interventions: Amber Glasses, Clear Lens Glasses; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 14 Years to 17 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Chicago, Illinois • Rochester, Minnesota

Conditions: Physician Fatigue
Interventions: SCS intervention schedule; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 413 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 6
States / cities: Aurora, Colorado • Iowa City, Iowa • Boston, Massachusetts + 3 more

Conditions: Obstructive Sleep Apnea
Interventions: Eclipse mask; Device
Lead sponsor: Bleep, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Asheville, North Carolina • Huntersville, North Carolina • Murfreesboro, Tennessee

Conditions: Stress Resilience, Systemic Inflammation, General Wellbeing, Sleep Quality, Safety
Interventions: Mycolicibacterium petrae KGA-10 (heat-killed), Placebo (microcrystalline cellulose); Dietary Supplement
Lead sponsor: Kioga Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Sleep, Diet Modification
Interventions: Diet Quality; Other
Lead sponsor: University of Chicago; Other
Eligibility: 21 Years to 40 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sleep Initiation and Maintenance Disorders
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 20 Years to 75 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Obesity, Obstructive Sleep Apnea
Interventions: Maridebart cafraglutide, Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 13
States / cities: Northridge, California • Rolling Hills Estates, California • Brandon, Florida + 10 more

Conditions: Insomnia, Delayed Sleep Phase
Interventions: mTranS-C, Control; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 12 Years to 18 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: REM Behavior Disorder
Interventions: Tasimelteon; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Restless Legs Syndrome (RLS), Restless Legs Syndrome
Interventions: Ropinirole; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 49
States / cities: Alabaster, Alabama • Birmingham, Alabama • Jasper, Alabama + 44 more

Conditions: Obstructive Sleep Apnea, Tonsillitis
Interventions: Hydromorphone, Fentanyl; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 2 Years to 15 Years
Enrollment: 189 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Rainbow Acoustic Monitoring (RAM) Clinical Engineering Data Collection

Continous Positive Airway Pressure (CPAP) Compliance Study

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea

Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia

Belun Ring Platform With an Improved Algorithm for OSA Assessment

Comparison Across Multiple Types of Sleep Deprivation

DRonabinol Treatment of OSA

Respicardia, Inc. Pivotal Trial of the remedē System

Effect of Continuous Positive Airway Pressure (CPAP) on Lower Esophageal Sphincter Pressure in Morbidly Obese Patients

Effects of Insomnia Treatment on Metabolism in Patients With Depression

Corneal Sensitivity in Patients With Sleep Apnea Syndrome

Glasses for Adolescent Delayed Sleep-Wake Phase Disorder

Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety

Field Usability Study of Eclipse Mask

Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and Inflammation

Diet and Sleep Monitoring

Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

The Reducing Risk Study

The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery